Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

Life Sciences Sector Applauds Office For Life Sciences "Life Sciences Blueprint" As A Major Milestone Towards Securing The Future Of The UK Industry
The UK"s life sciences trade associations - the Association of British Healthcare Industries (ABHI), the Association of the British Pharmaceutical Industry (ABPI), the BioIndustry Association (BIA) and the British In Vitro Diagnostic Association (BIVDA) - believe the package of measures announced today by the Office for Life Sciences in its "Life Sciences Blueprint" provide an excellent basis for firmly securing the future of the life sciences sector and re-establishing the UK"s global competitive position.
generic viagra online
Oncothyreon Announces Presentation Of Long-term Stimuvax Data At World Conference On Lung Cancer
Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY) (the "Company") announced that clinical data relating to long-term treatment with Stimuvax were presented at the International Association for the Study of Lung Cancer"s 13th World Conference on Lung Cancer in San Francisco on August 1, 2009. The presentation by Dr. Glenwood Goss from the Ottawa Hospital Cancer Centre, Ottawa, Ontario, involved 16 patients who received treatment with Stimuvax for between 2 and 8.2 years as part of the Phase 2b trial in patients with stage IIIb/IV non-small cell lung cancer (NSCLC).
News of the day
British Veterinary Association Welcomes Challenges Set Out For Profession
The British Veterinary Association has welcomed the publication of Professor Lowe"s report "Unlocking Potential: a report on veterinary expertise in food animal production" aiming to tackle some of the concerns raised by the Environment, Food and Rural Affairs Select Committee inquiry into vets and veterinary services in 2003.
Medical Devices

APEX Guides: Helping PBC Leaders To Become World Class Commissioners

The first three guides - Clinical Engagement, Governance and Prioritising Investment - will be launched at the Practice Based Commissioning National Forum, on 1 July. A fourth guide, on Patient and Public Engagement, will be published over the summer and a fifth, on Procurement, is already in the pipeline and expected to be published in September. APEX recognises that commissioners will have to make tough decisions to bring costs down while focusing on quality. Practice-based commissioning will be crucial in this process by bringing Primary Care Trusts (PCTs) and clinicians together. Dr David Jenner, Practice Based Federation Lead, NHS Alliance, said: "We want to promote the partnership between PBC and PCTs through effective commissioning. The APEX guides will help practice based commissioners develop to become world class commissioners with their PCTs by demonstrating what true world class commissioning would look like in action." Mark Hill, co-chair for APEX and Market Access Director at Novartis UK, said: "I am delighted that Novartis have collaborated with the NHS Alliance to develop these innovative commissioning competency guides. I firmly believe that the APEX guides will foster a productive relationship between PBC and PCTs and help to drive and deliver excellence in WCC". All guides are being developed through focus groups and discussions with key health service professionals. APEX is also currently developing a website which will become a platform for commissioners to share their experience and examples of best practice. NHSA members can download free copies of the guides from the NHS Alliance"s website at http://www.nhsalliance.org Notes 1. APEX is a practical, collaborative network, driving best practice and catalysing positive change for patients through practice-based commissioning (PBC). The APEX membership comprises a multidisciplinary group of PBC leaders who are representative of SHAs, and includes local PBC Group Chairs, SHA Commissioning Heads, and PCT Chief Executives and commissioning directors. Through a series of strategic, action-led initiatives, the aims of APEX are to: - drive best practice and catalyse positive change for patients through practice-based commissioning; - translate the ideas of clinicians into successful plans for PCTs; - help strategic health authorities (SHAs), PCTs and practices turn "talk" into "action", and - demonstrate and pioneer models of collaboration between industry and the NHS. 2. APEX is sponsored by an unrestricted grant by Novartis Pharmaceuticals Ltd APEX


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009